INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 X, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 0000 (Telephone: 000-000-0000). In addition, one copy of the annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed below. The final invention statement (see FAR 27.303(a)(2)(ii)) shall be submitted within 90 days after contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXX, XXXXX, NIH, DHHS 0000-X Xxxxxxxxx Xxxxx, Xxxx 0000, XXX 0000 Bethesda, Maryland 20892 - 7612 To assist contractors in complying with invention reporting requirements of the clause, the NIH has developed “Interagency Edison,” an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 2 contracts
Samples: Contract (Coley Pharmaceutical Group, Inc.), Contract (Coley Pharmaceutical Group, Inc.)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 11, Patent Rights-Ownership by the Contractor including, but not limited to, the invention disclosure report, the confirmatory license, and the government Government support certification, shall be directed to the Division of Extramural Inventions and Technology Resources BranchResources(DEITR), OPERA, OER, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 XXxxxx 000, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000-000-0000). In addition, one copy of the an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed belowOfficer. The final invention statement (see FAR 27.303(a)(2)(ii27.303(b)(2)(ii)) shall be submitted within 90 days after contract to the Contracting Officer on the expiration date of the contract. The annual utilization report shall be submitted in accordance with the DELIVERIES Article in SECTION F of this contract. The final invention statement (see FAR 27.303(b)(2)(ii)) shall be submitted on the expiration date of the contract. All reports shall be sent to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health Xxxxxx Xxxxxxxxxx Office of Acquisitions 0000 Xxxxxxxx Xxxxx Riverside Five, XXXXXSuite 400, NIHRoom 4031 Frederick, DHHS 0000-X Xxxxxxxxx XxxxxMD 21701- 4998 If no invention is disclosed or no activity has occurred on a previously disclosed invention during the applicable reporting period, Xxxx 0000, XXX 0000 Bethesda, Maryland 20892 - 7612 a negative report shall be submitted to the Contracting Officer at the address listed above. To assist contractors in complying with invention reporting requirements of the clause, the NIH has developed “Interagency Edison,” an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 2 contracts
Samples: Supplemental Agreement (Mabvax Therapeutics Holdings, Inc.), Supplemental Agreement (Mabvax Therapeutics Holdings, Inc.)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 XA, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000-000-0000). In addition, one copy of the annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed below. The final invention statement (see FAR 27.303(a)(2)(ii)) shall be submitted within 90 days after on the expiration date of the contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health National Institute of Allergy and Infectious Diseases, XXXXX, NIH, DHHS 0000-X CMB 0000X Xxxxxxxxx Xxxxx, Xxxx 0000, XXX 0000 Bethesda7612 Xxxxxxxx, Maryland 20892 Xxxxxxxx 00000 - 7612 To assist contractors in complying with invention reporting requirements of the clause, the NIH has developed “"Interagency Edison,” " an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. SECTION D - PACKAGING, MARKING AND SHIPPING All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 1 contract
Samples: Contract (Acambis PLC)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 XA, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000-000-0000). In addition, one copy of the an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed belowOfficer. The final invention statement (see FAR 27.303(a)(2)(ii)) shall be submitted to the Contracting Officer within 90 days after the expiration date of the contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health National Institute of Allergy and Infectious Diseases, XXXXX, NIH, DHHS CMP 0000-X Xxxxxxxxx Xxxxx, Xxxx 0000, XXX 0000 Bethesda7612 Xxxxxxxx, Maryland 20892 Xxxxxxxx 00000 -7612 If no invention is disclosed or no activity has occurred on a previously disclosed invention during the applicable reporting period, a negative report shall be submitted to the Contracting Officer at the address listed above. APPENDIX A - 7612 PRIME CONTRACT FLOWDOWNS CHOP REFERENCE NO. 22852 -01-01 To assist contractors Contractors in complying with invention reporting requirements of the clause, the NIH has developed “"Interagency Edison,” " an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 1 contract
Samples: Subcontract Agreement (Targeted Genetics Corp /Wa/)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 X, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000-000-0000). In addition, one copy of the an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed belowOfficer. The final invention statement (see FAR 27.303(a)(2)(ii)) shall be submitted to the Contracting Officer within 90 days after the expiration date of the contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health National Institute of Allergy and Infectious Diseases, XXXXX, NIH, DHHS CMB 0000-X Xxxxxxxxx Xxxxx, Xxxx 0000, XXX 0000 Bethesda, Maryland 20892 - 7612 -7612 If no invention is disclosed or no activity has occurred on a previously disclosed invention during the applicable reporting period, a negative report shall be submitted to the Contracting Officer at the address listed above. To assist contractors Contractors in complying with invention reporting requirements of the clause, the NIH NTH has developed “Interagency Edison,” an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 1 contract
Samples: Contract (Pharmathene, Inc)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 6000 Xxxxxxxxx Xxxxx, Xxxx 0000 X, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000300-000-0000). In 0000).In addition, one copy of the an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed belowOfficer. The final invention statement (see FAR 27.303(a)(2)(ii)) » shall be submitted within 90 days after to the Contracting Officer on the expiration date of the contract. The final invention statement (see FAR 27.303(a)(2)(ii» shall be submitted on the expiration date of the contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health National Institute of Allergy and Infectious Diseases, XXXXX, NIH, DHHS 0000-X CMP 6000X Xxxxxxxxx Xxxxx, Xxxx 0000, XXX 0000 BethesdaXxxxxxxx, Maryland 20892 - Xxxxxxxx 00000 — 7612 If no invention is disclosed or no activity has occurred on a previously disclosed invention during the applicable reporting period, a negative report shall be submitted to the Contracting Officer at the address listed above. To assist contractors in complying with invention reporting requirements of the clause, the NIH has developed “Interagency Edison,” an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxxhxxx://xxx.xxxxxxx.xxx), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 1 contract
Samples: Contract (Acambis PLC)
INVENTION REPORTING REQUIREMENT. All reports and documentation required by FAR Clause 52.227-11 including, but not limited to, the invention disclosure report, the confirmatory license, and the government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 0000 Xxxxxxxxx Xxxxx, Xxxx 0000 X, XXX 0000, Xxxxxxxx, Xxxxxxxx 00000- 00000-0000 (Telephone: 000-000-0000). In addition, one copy of the an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer at the address listed belowOfficer. The final invention statement (see FAR 27.303(a)(2)(ii)) shall be submitted to the Contracting Officer within 90 days after the expiration date of the contract expiration to the following address: Contracting Officer Preclinical Research Contracts Branch Contract Management Program XXXNational Institutes of Health National Institute of Allergy and Infectious Diseases, XXXXX, NIH, DHHS CMB 0000-X Xxxxxxxxx Xxxxx, Xxxx 00000000 Xxxxxxxx, XXX Xxxxxxxx 00000-0000 BethesdaIf no invention is disclosed or no activity has occurred on a previously disclosed invention during the applicable reporting period, Maryland 20892 - 7612 a negative report shall be submitted to the Contracting Officer at the address listed above. To assist contractors Contractors in complying with invention reporting requirements of the clause, the NIH has developed “Interagency Edison,” an electronic invention reporting system. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (xxxx://xxx.xxxxxxx.xxx), ) or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Appears in 1 contract